Bo Ying

Company: AboGen Inc.

Job title: Chief Executive Officer

Bio:

Dr. Bo Ying is the Chief Executive Officer of Abogen Biosciences, a company focused on delivering transformative therapies through mRNA innovation. He has almost twenty years of experiences working in the field of nucleic acid research, he has also served as group leaders at Dicerna (now acquired by novo nordisc) and Moderna. Dr. Ying received his bachelor’s and master’s degrees from Fudan University and his Ph.D. degree from Northeastern University in Boston, USA.

Seminars:

Unlocking Recent Clinical Progress of mRNA-Based Vaccines & B-Cell Depletion Therapies 9:00 am

Demonstrating Abogen’s unique mRNA and LNP platform Sharing clinical data and progress of mRNA cancer vaccines Accelerating preclinical and clinical development of mRNA-based T-cell engagers and in vivo CAR-TRead more

day: Conference Day One

CEO Leaders Think Tank – Accelerating the Next Wave of RNA-Based Therapeutics & Vaccines to Develop Safe & Efficacious Drugs to Commercial Reality 2:20 pm

The Asian biopharmaceutical sector is thriving in RNA innovation, manufacturing advancements and strategic alliances to enhance the knowledge, skills, and experience across the region to become the powerhouse of commercial success. Hear from pioneering executive leaders across mRNA and next generation RNAs who will discuss their ambitions, strategies and challenges for the future of this…Read more

day: Conference Day One